| Date | Form | Description | Docs | XBRL | Pages |
| 09/19/22 | EFFECT | Notice of Effectiveness |
|
1 | |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/12/22 | DEL AM | Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement |
|
1 | |
| 09/09/22 | S-3 | Registration statement for specified transactions by certain issuers |
|
68 | |
| 09/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
21 |
| 08/17/22 | 8-K | Current report filing |
|
|
2 |
| 06/28/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 05/02/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposium
Read More...Anixa Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Read More...Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial
Read More...